Skip to main content
main-content

Medicine Matters oncology

Monash University, Australia

New Content Item

Professor Segelov was appointed Professor and Director of Oncology at Monash University and Monash Health, Melbourne, Victoria, in February 2017. Prior to this, she was Associate Professor of Medicine, University of New South Wales and Senior Medical Oncologist at St Vincent’s Hospital, Sydney. She has specialist interest in the diagnosis and management of upper and lower gastrointestinal cancers, including neuroendocrine tumours and anal cancer.

Professor Segelov is the international lead on the ICECREAM and ASCOLT international trials and has been Australian lead on multiple studies. She has published over 70 articles, expert reviews and book chapters and is frequently an invited speaker at national and international conferences.

Professor Segelov is an ESMO faculty member for the CUP, Endocrine Tumours and Others group; member of the Editorial Board of Journal of Global Oncology (ASCO) 2015-present and the Track co-Chair, Gastrointestinal Cancer, ESMO Asia Annual Scientific Meeting 2017-9. In 2015 she co-founded the international research collaborative group CommNETS (Commonwealth Neuroendocrine Tumour Society).

Professor Segelov was awarded the University of New South Wales Vice Chancellor’s Award for Teaching Excellence for developing flagship preceptorship programmes in multiple cancer subtypes, teaching the advent of modern cancer treatments through the understanding of seminal research papers. Eva is a Board member of the Australasian Gastro-Intestinal Trials Group (AGITG) and the Chair of Gastrointestinal Cancer of the Clinical Oncological Society of Australia (COSA).